Bliss GVS Pharma Limited has informed the Exchange about Intimation of WHO-GMP Compliance of Manufacturing Facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East).
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma has informed the exchange that its manufacturing facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East) has achieved WHO-GMP (World Health Organization – Good Manufacturing Practice) compliance. WHO-GMP is a globally recognised quality standard required for pharmaceutical manufacturing, particularly for products supplied to regulated international markets and global health agencies. This compliance status upgrades the facility's manufacturing credentials and removes a key regulatory barrier for export-oriented production. It is a positive operational and regulatory milestone for the company.
Mildly positive for shareholders as WHO-GMP compliance broadens the company's addressable markets, supports export ambitions, and strengthens its standing with international buyers and regulators. Likely to be a sentiment-positive announcement rather than an immediate financial trigger.